Comments
Loading...

Dare Bioscience

DARENASDAQ
Logo brought to you by Benzinga Data
$3.23
0.051.57%
At close: -
$3.17
-0.06-1.86%
After Hours: Nov 20, 9:25 AM EDT

Dare Bioscience (NASDAQ:DARE) Stock Quotes, Forecast and News Summary

Dare Bioscience Stock (NASDAQ: DARE) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Aug
1
Oct
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$3.19
Close$3.23
Volume / Avg.52.17K / 40.97K
Day Range$3.18 - $3.31
52 Wk Range3.05 - 7.56
Market Cap$27.58M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
38
Short Interest
0.34%
Days to Cover1

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
DARE
CPIX

FAQ

Q

How do I buy Dare Bioscience (DARE) stock?

A

You can purchase shares of Dare Bioscience (NASDAQ:DARE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Dare Bioscience (DARE) competitors?

Q

What is the forecast, or price target, for Dare Bioscience (DARE) stock?

A

Dare Bioscience has a consensus price target of $8.50.

Q

What is the current price for Dare Bioscience (DARE)?

A

The stock price for Dare Bioscience (NASDAQ: DARE) is $3.17 last updated November 20, 2024 at 9:25 AM EST.

Q

Does Dare Bioscience (DARE) pay a dividend?

A

There are no upcoming dividends for Dare Bioscience.

Q

When is Dare Bioscience (NASDAQ:DARE) reporting earnings?

A

Dare Bioscience’s Q3 earnings are confirmed for Thursday, November 14, 2024.

Q

Is Dare Bioscience (DARE) going to split?

A

There is no upcoming split for Dare Bioscience.

Q

What sector and industry does Dare Bioscience (DARE) operate in?

A

Dare Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch